整合个性化医疗的医疗实践策略：新冠疫情的管理
Healthcare practice strategies for integrating personalized medicine: Management of COVID-19.
作者信息
Liu Wen-Yi, Chien Ching-Wen, Tung Tao-Hsin
机构信息
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, MD 21205, United States; Shanghai Bluecross Medical Science Institute, Shanghai 201100, Shanghai Province, China.
Institute for Hospital Management, Tsing Hua University, Shenzhen Campus, Shenzhen 518055, Guangdong Province, China.
出版信息
World J Clin Cases. 2021 Oct 16;9(29):8647-8657. doi: 10.12998/wjcc.v9.i29.8647.
Personalized medicine is the tailor-made clinical treatment to the individual characteristics of each patient. It may be considered an extension of traditional approaches to knowing and treating diseases. Personalized medicine has the potential to change the way of identification and management of health problems. Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the patients' lungs. The first case of pneumonia of unknown cause was reported in Wuhan, China on December 31, 2019. As thus, we are quickly approaching the era of personalized medicine. This review discusses the practices currently used in the management of COVID-19 and how they relate to personalized medicine.
个性化医疗是根据每位患者的个体特征量身定制的临床治疗方法。它可以被视为传统疾病认知和治疗方法的延伸。个性化医疗有可能改变健康问题的识别和管理方式。2019冠状病毒病（COVID-19）是一种主要影响患者肺部的传染病。2019年12月31日，中国武汉报告了首例病因不明的肺炎病例。因此，我们正在迅速迈入个性化医疗时代。本综述讨论了目前用于管理COVID-19的实践方法以及它们与个性化医疗的关系。
Zotero 插件